期刊文献+

心脏重症监护病房患者分级药学监护档案表的建立 被引量:1

Establishment of the grading pharmaceutical care file table for CCU patients
下载PDF
导出
摘要 目的:建立心脏重症监护病房(CCU)个体化分级药学监护档案表,对患者进行全程药学监护。方法:结合CCU临床诊疗实际情况,回顾性搜集、整理和掌握患者的用药信息,根据实际情况定义监护等级,创建分级药学监护档案表。结果:分级药学监护档案表的制定大大提高临床药师的工作效率,患者的用药情况得到极大的规范和合理。结论:建立分级药学监护档案表,将协助医师用药做到个体化,努力实现"用药者健康利益最大化,药源性损害与成本最小化"。 Objective: To establish a grading pharmaceutical care file table for CCU patients so that the whole process of pharmaceutical care can be implemented to the patients. Methods: Medication information about the patients was collected and retrospectively analyzed based on the actual situation of the clinical diagnosis and treatment at CCU, the monitoring level was defined based on the actual situation and a grading pharmaceutical care file table was finally established. Results: The working efficiency of the clinical pharmacists could be greatly improved and medication in the patients could be greatly standardized and trended to be more reasonable by the established table. Conclusion: The table will help physicians achieve individualized medication, and make an effort for drug users to achieve maximal health benefits and minimal drug-induced damage and cost.
出处 《上海医药》 CAS 2016年第21期54-56,共3页 Shanghai Medical & Pharmaceutical Journal
基金 上海市卫生局青年科研项目(项目编号:20134Y208)
关键词 心脏重症监护病房 分级 药学监护 CCU grading pharmaceutical care
  • 相关文献

参考文献10

二级参考文献84

  • 1蒋霞,李耘,蔡映云.对临床药师培养的几点思考[J].上海医药,2005,26(8):372-373. 被引量:8
  • 2陈龙飞,陆曦,吴钢,许国英.甲状腺功能减退性肌病3例[J].实用医学杂志,2007,23(1):84-86. 被引量:4
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2108
  • 4Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/ STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization [J]. Ciurculation, 2009, 119 (9) : 1330-1352.
  • 5Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST elevation and non-ST-elevation myocardial infarction: a report of the Ameri can College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST elevation and non-ST-elevation myocardial infarction): developed in collaboration with the A merican Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Assoclarion of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine [J]. Ciurculation, 2008, 118 (24): 2596- 2648.
  • 6Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA ACS randomized trial [J]. J Am Coll Cardiol, 2007, 49 (12): 1272-1278.
  • 7Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents [J]. J Am Coll Cardiol, 2008, 52 (18): 1502-1517.
  • 8Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome [J].Jama, 2009, 301 (9): 937- 944.
  • 9Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel[J]. CMAJ, 2009, 180 (7): 713- 718.
  • 10中共中央,国务院.关于深化医药卫生体制改革的意见[S].2009-03-17.

共引文献89

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部